Skip to main contentAll experts

Mario Mietzsch

RES AST PROF

MD-BIOCHEM - MOLECULAR BIOL

Orcid identifier0000-0001-8957-3363 (opens in a new tab)⁠
  • RES AST PROF
    MD-BIOCHEM - MOLECULAR BIOL

GRANTS

  • GRANT
    Structural and Biophysical Characterization of AAV Genome Packaging and Ejection for Enhanced Vector Design
    National Institute of Health Niaid14 Jul 2026 - 30 Jun 2028
    Active
  • GRANT
    High Resolution Structural characterization of AAV capsid ligand complexes
    Repligen Corporation20 Dec 2025 - 28 Feb 2026
    Expired
  • GRANT
    Engineering AAV for safe and efficient gene delivery to the human retina
    National Institute of Health Nei5 Sep 2024 - 30 Jun 2029
    Active
  • GRANT
    Leaving no child behind: enabling universal access to AAV gene therapies by vector bio-engineering to evade pre-existing natural immunity
    National Health and Med Research Council9 Jul 2024 - 31 Dec 2027
    Active
  • GRANT
    AAV capsids and their cellular interactions
    National Institute of Health Nigms22 Apr 2024 - 31 Jan 2028
    Active
  • GRANT
    Structural characterization of AAV capsid ligand complexes
    Avitide3 Apr 2024 - 12 Apr 2024
    Expired
  • GRANT
    A modified arrestin1 to enhance glycolysis in photoreceptors as a therapeutic approach to slowing retinal degeneration
    National Institute of Health Nei8 Dec 2023 - 31 Dec 2028
    Active
  • GRANT
    Structural characterization of AAV capsid ligand complexes
    Avitide14 Nov 2023 - 18 Jan 2024
    Expired
  • GRANT
    A study into the expression of TTV and its possible development as a gene therapy vector#######
    Intima Bioscience6 Oct 2022 - 30 Oct 2023
    Expired
  • GRANT
    Cryo-EM analysis of AAV capsid full/empty ratio determinations
    Stridebio3 Jan 2022 - 31 Jul 2022
    Expired
  • GRANT
    Generation of AAV1 VP3-only DNA empty capsids
    Thermo Finnigan9 Dec 2021 - 14 Jan 2022
    Expired
  • GRANT
    Generation of AAV1 VP3 only DNA empty capsids
    Thermo Finnigan20 Jul 2021 - 1 Oct 2021
    Expired
  • GRANT
    A role for AAV Rep in genome packaging efficiency
    Intima Bioscience5 Jun 2018 - 30 Apr 2022
    Expired
  • GRANT
    AAV1 Variants for CNS Targeted Therapies
    Voyager Therapeutics Inc15 Dec 2016 - 9 May 2022
    Expired